TAI-LING BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.2 TWD | +1.14% |
|
-0.80% | -.--% |
| 2019 | Tai-Ling Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
| 2019 | Tai Ling Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2018 | CI |
| Sales 2017 | 330M 10.13M 811M | Sales 2018 | 342M 10.49M 839M | Capitalization | 293M 8.98M 719M |
|---|---|---|---|---|---|
| Net income 2017 | -35M -1.07M -85.95M | Net income 2018 | 12M 368K 29.47M | EV / Sales 2017 | 1.12 x |
| Net Debt 2017 | 68.44M 2.1M 168M | Net Debt 2018 | 100M 3.08M 246M | EV / Sales 2018 | 1.15 x |
| P/E ratio 2017 |
-8.55
x | P/E ratio 2018 |
24.1
x | Employees | - |
| Yield 2017 * |
-
| Yield 2018 |
3.66% | Free-Float | 0% |
More Fundamentals
* Assessed data
| 1 day | +1.14% |
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Fu Liu
CEO | Chief Executive Officer | - | 28/02/05 |
Tzu Hui Wang
DFI | Director of Finance/CFO | - | 31/03/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chi Hsiung Lin
BRD | Director/Board Member | - | - |
Han Fei Lin
BRD | Director/Board Member | - | 11/01/15 |
Chi Li Chang
BRD | Director/Board Member | - | - |
Tai-Ling Biotech Inc. is a Taiwan-based company mainly engaging in breeding, research and development, tissue culture, cultural production and sales of phalaenopsis. The Company offers seedlings, cut flowers and bottle seedlings of phalaenopsis. Its products include bottle seedlings, OEM of bottle seedlings, plantlets, middle age seedlings, big seedlings, flowering plants and cut flowers, among others. The Company distributes its products within domestic markets and to overseas markets, including Taiwan, Japan, Europe, American and other areas.
Sector
-
- Stock Market
- Equities
- 8496 Stock
